July 2026
1. VAN DER MEER D, Shadrin AA, Stinson SE, Koch E, et al
   Divergent Patterns of Genetic Overlap Between Severe Mental Disorders and Metabolic Markers.
   Am J Psychiatry. 2026;183:482-493.
   

   >> Share

   
   June 2026
2. KALIN NH
   Treating Severe Depression and Suicidality.
   Am J Psychiatry. 2026;183:367-369.
   

   >> Share

   
   
3. KELLNER CH, Jelovac A, Braithwaite R
   Relapse Prevention After Successful ECT for Depression: The Role of Lithium and Continuation/Maintenance ECT.
   Am J Psychiatry. 2026;183:370-372.
   

   >> Share

   
   
4. TUCCIARONE JM, Bandeira ID, Blasey C, Kratter IH, et al
   Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
   Am J Psychiatry. 2026;183:409-419.
   

   >> Share

   
   
5. JELEN LA, O'Daly O, Zelaya FO, Stone JM, et al
   Regional Blood Flow Signatures of Opioidergic Modulation of Ketamine in Major Depressive Disorder: A Randomized Crossover Study.
   Am J Psychiatry. 2026;183:420-430.
   

   >> Share

   
   
6. ROVERS JJE, van Eijndhoven PFP, Abbot C, Argyelan M, et al
   A Global Delphi-Based Expert Consensus on Relapse Prevention Strategies Following Successful Electroconvulsive Therapy for Major Depressive Disorder.
   Am J Psychiatry. 2026;183:401-408.
   

   >> Share

   
   May 2026
7. BLUMBERGER DM, Vila Rodriguez F, McClintock SM, Thorpe KE, et al
   Clinical and Cognitive Outcomes Comparing Right Unilateral Ultrabrief Electroconvulsive Therapy Versus Magnetic Seizure Therapy for Bipolar Depression: The CORRECT-BD Trial.
   Am J Psychiatry. 2026 May 6:appiajp20250955. doi: 10.1176/appi.ajp.20250955.
   

   >> Share

   
   March 2026
8. VALIENGO LDCL, Pinto BS, Luethi M, Afonso Santos L, et al
   Bilateral Theta-Burst Stimulation of Dorsolateral Prefrontal Cortex Regions for Late-Life Depression: A Randomized, Sham-Controlled Clinical Trial.
   Am J Psychiatry. 2026 Mar 11:appiajp20250537. doi: 10.1176/appi.ajp.20250537.
   

   >> Share

   
   January 2026
9. BLOCH MH, Dwyer JB
   Potentially Problematic Research Practices in a Study on Ketamine for Pediatric Depression: Response to Ploderl and Moncrieff.
   Am J Psychiatry. 2026;183:83-85.
   

   >> Share

   
   
10. PLODERL M, Moncrieff J
    Potentially Problematic Research Practices in a Study on Ketamine for Pediatric Depression.
    Am J Psychiatry. 2026;183:82-83.
    

    >> Share

    
    
11. KALIN NH
    Externalizing Disorders, Pediatric Anxiety, Autism, and Inflammation-Related Depression.
    Am J Psychiatry. 2026;183:1-3.
    

    >> Share

    
    
12. MAC GIOLLABHUI N, Madison AA, Lydston M, Lenoel Quang E, et al
    Effect of Anti-Inflammatory Treatment on Depressive Symptom Severity and Anhedonia in Depressed Individuals With Elevated Inflammation: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Am J Psychiatry. 2026;183:70-79.
    

    >> Share

    
    December 2025
13. KALIN NH
    Updates and Advances in the Treatment of Substance Use Disorders, Depression, and Borderline Personality Disorder.
    Am J Psychiatry. 2025;182:1029-1031.
    

    >> Share

    
    
14. DURGAM S, Earley WR, Kozauer SG, Mo Y, et al
    Adjunctive Lumateperone in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial.
    Am J Psychiatry. 2025;182:1072-1082.
    

    >> Share

    
    
15. BRODSKY BS, Galfalvy H, Mann JJ, Grunebaum MF, et al
    Dialectical Behavior Therapy Versus Serotonin Reuptake Inhibitor Treatment for Suicidal Behavior in Borderline Personality Disorder: A Randomized Controlled Trial.
    Am J Psychiatry. 2025;182:1083-1092.
    

    >> Share

    
    October 2025
16. KALIN NH
    Adolescent Suicidality and Depression, Premenstrual Dysphoric Disorder, and Safety Issues Related to Ketamine and Esketamine Treatment.
    Am J Psychiatry. 2025;182:889-891.
    

    >> Share

    
    
17. WEI SM, Wakim P, Martinez PE, Nieman LK, et al
    Differential Effects of Ovarian Steroids in Women With and Without Premenstrual Dysphoric Disorder: A Replication and Extension of Findings.
    Am J Psychiatry. 2025;182:922-934.
    

    >> Share

    
    
18. FOUNTOULAKIS KN, Saitis A, Schatzberg AF
    Esketamine Treatment for Depression in Adults: Response to Price et al. and Canuso et al.
    Am J Psychiatry. 2025;182:954-956.
    

    >> Share

    
    
19. CANUSO CM, Bossie C, Fu DJ, Lane R, et al
    Comment on Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis.
    Am J Psychiatry. 2025;182:951-954.
    

    >> Share

    
    
20. WHITTLE S, Rakesh D, Simmons JG, Schwartz O, et al
    Prospective Associations Between Structural Brain Development and Onset of Depressive Disorder During Adolescence and Emerging Adulthood.
    Am J Psychiatry. 2025;182:935-944.
    

    >> Share

    
    September 2025
21. LI SW, Kumpf KT, Urrutia J, Krystal JH, et al
    Ketamine for Depression, but at What Cost? A Review of Ketamine's Neurotoxic Effects From Preclinical and Human Studies.
    Am J Psychiatry. 2025 Sep 10:appiajp20250276. doi: 10.1176/appi.ajp.20250276.
    

    >> Share

    
    July 2025
22. AHN Y, Kim J, Jung K, Lee DJ, et al
    Relationship Between Problematic Alcohol Use and Various Psychiatric Disorders: A Genetically Informed Study.
    Am J Psychiatry. 2025;182:671-682.
    

    >> Share

    
    June 2025
23. FONZO GA, Doss MK, Nemeroff CB
    There's More Than One Way to Bring Health Back: Divergent Effects of Psilocybin and Escitalopram Treatment on Emotional Brain Function in Depression.
    Am J Psychiatry. 2025;182:512-515.
    

    >> Share

    
    
24. KALIN NH
    Depression, Inflammation, and Postpartum Psychosis.
    Am J Psychiatry. 2025;182:501-503.
    

    >> Share

    
    
25. SAVITZ J, Figueroa-Hall LK, Teague TK, Yeh HW, et al
    Systemic Inflammation and Anhedonic Responses to an Inflammatory Challenge in Adults With Major Depressive Disorder: A Randomized Controlled Trial.
    Am J Psychiatry. 2025;182:560-568.
    

    >> Share

    
    May 2025
26. CLAPP MA, Castro VM, Verhaak P, McCoy TH, et al
    Stratifying Risk for Postpartum Depression at Time of Hospital Discharge.
    Am J Psychiatry. 2025 May 19:appiajp20240381. doi: 10.1176/appi.ajp.20240381.
    

    >> Share

    
    
27. MILLER AH
    Advancing an Inflammatory Subtype of Major Depression.
    Am J Psychiatry. 2025 May 7:appiajp20250289. doi: 10.1176/appi.ajp.20250289.
    

    >> Share

    
    
28. WALL MB, Demetriou L, Giribaldi B, Roseman L, et al
    Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression.
    Am J Psychiatry. 2025 May 7:appiajp20230751. doi: 10.1176/appi.ajp.20230751.
    

    >> Share

    
    
29. RUGGIERO KJ, Andrews A, Davidson TM, Gavrilova Y, et al
    Randomized Controlled Trial of "Bounce Back Now," a Mobile App to Reduce Post-Disaster Symptoms of Posttraumatic Stress, Depressed Mood, and Sleep Disturbance.
    Am J Psychiatry. 2025;182:463-472.
    

    >> Share

    
    
30. TANG VM, Aaronson S, Abdelghani M, Baeken C, et al
    Assessment and Management of Concurrent Substance Use in Patients Receiving Repetitive Transcranial Magnetic Stimulation for Depressive, Obsessive-Compulsive, Psychotic, and Trauma-Related Disorders: A Delphi Consensus Study and Guideline.
    Am J Psychiatry. 2025;182:438-451.
    

    >> Share

    
    April 2025
31. CHEN L, Fukuda AM, Jiang S, Leuchter MK, et al
    Treating Depression With Repetitive Transcranial Magnetic Stimulation: A Clinician's Guide.
    Am J Psychiatry. 2025 Apr 30:appiajp20240859. doi: 10.1176/appi.ajp.20240859.
    

    >> Share

    
    March 2025
32. KALIN NH
    New Developments in the Treatment of Depression, OCD, and Schizophrenia.
    Am J Psychiatry. 2025;182:223-226.
    

    >> Share

    
    
33. MATHEW SJ, Murphy N
    Six Years After Approval of Esketamine Nasal Spray for Serious Depression: Clinical Conundrums and Unanswered Questions.
    Am J Psychiatry. 2025;182:227-230.
    

    >> Share

    
    
34. BRUNONI AR, Padberg F
    Spaced Transcranial Direct Current Stimulation for Depression: The Road Less Traveled.
    Am J Psychiatry. 2025;182:231-233.
    

    >> Share

    
    February 2025
35. KING AC, Fischer AM, Cursio JF, Didier NA, et al
    Real-Time Assessment of Alcohol Reward, Stimulation, and Negative Affect in Individuals With and Without Alcohol Use Disorder and Depressive Disorders.
    Am J Psychiatry. 2025;182:187-197.
    

    >> Share

    
    
36. KYPRIOTAKIS G, Cinciripini PM, Green CE, Lawrence D, et al
    Effects of Varenicline, Bupropion, Nicotine Patch, and Placebo on Treating Smoking Among Persons With Current or Past Major Depressive Disorder: Secondary Analysis of a Double-Blind, Randomized, Placebo-Controlled Trial.
    Am J Psychiatry. 2025;182:174-186.
    

    >> Share

    
    January 2025
37. FOUNTOULAKIS KN, Saitis A, Schatzberg AF
    Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis.
    Am J Psychiatry. 2025 Jan 29:appiajp20240515. doi: 10.1176/appi.ajp.20240515.
    

    >> Share

    
    
38. COUTURE M, Desbeaumes Jodoin V, Bousseau E, Sarshoghi A, et al
    Spaced Transcranial Direct Current Stimulation for Major Depression.
    Am J Psychiatry. 2025 Jan 29:appiajp20240083. doi: 10.1176/appi.ajp.20240083.
    

    >> Share

    
    
39. MCINTYRE RS, Kwan ATH, Mansur RB, Oliveira-Maia AJ, et al
    Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research.
    Am J Psychiatry. 2025;182:21-32.
    

    >> Share

    
    
40. AARONSON ST, van der Vaart A, Miller T, LaPratt J, et al
    Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial.
    Am J Psychiatry. 2025;182:104-113.
    

    >> Share

    
    
41. RAMAEKERS JG, Reckweg JT, Mason NL
    Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression.
    Am J Psychiatry. 2025;182:33-46.
    

    >> Share

    
    
42. FONZO GA, Wolfgang AS, Barksdale BR, Krystal JH, et al
    Psilocybin: From Psychiatric Pariah to Perceived Panacea.
    Am J Psychiatry. 2025;182:54-78.
    

    >> Share

    
    
43. KIRLIC N, Lennard-Jones M, Atli M, Malievskaia E, et al
    Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions.
    Am J Psychiatry. 2025;182:126-132.
    

    >> Share

    
    December 2024
44. WIDOM CS, Courtney K, Do HH
    Pathways to Homelessness: Childhood Maltreatment and Psychiatric Symptoms Increase Risk of Homelessness.
    Am J Psychiatry. 2024;181:1103-1111.
    

    >> Share

    
    
45. GREY DK, Purcell JB, Buford KN, Schuster MA, et al
    Discrimination Exposure, Neural Reactivity to Stress, and Psychological Distress.
    Am J Psychiatry. 2024;181:1112-1126.
    

    >> Share

    
    October 2024
46. GALLUCCI J, Yu JC, Oliver LD, Nakua H, et al
    Neural Circuitry and Therapeutic Targeting of Depressive Symptoms in Schizophrenia Spectrum Disorders.
    Am J Psychiatry. 2024;181:910-919.
    

    >> Share

    
    
47. HWANG M, Brady R
    Neural Circuitry and Therapeutic Targeting of Depressive Symptoms in Schizophrenia Spectrum Disorders.
    Am J Psychiatry. 2024;181:858-860.
    

    >> Share

    
    September 2024
48. SOARES CN
    Contraception, Intrauterine Systems, and Depression: Can We Spot the Real Perpetrator?
    Am J Psychiatry. 2024;181:789-792.
    

    >> Share

    
    
49. MARTIN DM, Nikolin S
    "Closing the Loop" With Transcranial Electrical Stimulation for Depression.
    Am J Psychiatry. 2024;181:793-794.
    

    >> Share

    
    
50. KASTER TS, Blumberger DM
    Positioning rTMS Within a Sequential Treatment Algorithm of Depression.
    Am J Psychiatry. 2024;181:781-783.
    

    >> Share

    
    
51. KALIN NH
    Depression: Factors Contributing to Risk and Therapeutic Insights.
    Am J Psychiatry. 2024;181:777-780.
    

    >> Share

    
    
52. DALHUISEN I, van Oostrom I, Spijker J, Wijnen B, et al
    rTMS as a Next Step in Antidepressant Nonresponders: A Randomized Comparison With Current Antidepressant Treatment Approaches.
    Am J Psychiatry. 2024;181:806-814.
    

    >> Share

    
    
53. SCHWIPPEL T, Pupillo F, Feldman Z, Walker C, et al
    Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Major Depressive Disorder: An Open-Label Pilot Study.
    Am J Psychiatry. 2024;181:842-845.
    

    >> Share

    
    
54. HESS EM, Greenstein DK, Hutchinson OL, Zarate CA, et al
    Entactogen Effects of Ketamine: A Reverse-Translational Study.
    Am J Psychiatry. 2024;181:815-823.
    

    >> Share

    
    August 2024
55. SALVATORE JE, Ohlsson H, Sundquist J, Sundquist K, et al
    Peer Social Genetic Effects and the Etiology of Substance Use Disorders, Major Depression, and Anxiety Disorder in a Swedish National Sample.
    Am J Psychiatry. 2024 Aug 7:appiajp20230358. doi: 10.1176/appi.ajp.20230358.
    

    >> Share

    
    July 2024
56. LARSEN SV, Mikkelsen AP, Ozenne B, Munk-Olsen T, et al
    Association Between Intrauterine System Hormone Dosage and Depression Risk.
    Am J Psychiatry. 2024 Jul 10:appiajp20230909. doi: 10.1176/appi.ajp.20230909.
    

    >> Share

    
    
57. POLIMANTI R
    Using Medical Records to Investigate the Genetics of Treatment-Resistant Depression Across Health Care Systems.
    Am J Psychiatry. 2024;181:569-571.
    

    >> Share

    
    
58. AKIKI TJ, Abdallah CG
    Mapping the Depressed Brain Under Stress Using Multimodal Neuroimaging.
    Am J Psychiatry. 2024;181:578-580.
    

    >> Share

    
    
59. ROHDE C, Ostergaard SD, Jefsen OH
    A Nationwide Target Trial Emulation Assessing the Risk of Antidepressant-Induced Mania Among Patients With Bipolar Depression.
    Am J Psychiatry. 2024;181:630-638.
    

    >> Share

    
    
60. JONSSON L, Horbeck E, Primerano A, Song J, et al
    Association of Occupational Dysfunction and Hospital Admissions With Different Polygenic Profiles in Bipolar Disorder.
    Am J Psychiatry. 2024;181:620-629.
    

    >> Share

    
    May 2024
61. KANG J, Castro VM, Ripperger M, Venkatesh S, et al
    Genome-Wide Association Study of Treatment-Resistant Depression: Shared Biology With Metabolic Traits.
    Am J Psychiatry. 2024 May 15:appiajp20230247. doi: 10.1176/appi.ajp.20230247.
    

    >> Share

    
    April 2024
62. BAUM ML, Widge AS, Carpenter LL, McDonald WM, et al
    Pharmacogenomic Clinical Support Tools for the Treatment of Depression.
    Am J Psychiatry. 2024 Apr 30:appiajp20230657. doi: 10.1176/appi.ajp.20230657.
    

    >> Share

    
    
63. IRONSIDE M, Duda JM, Moser AD, Holsen LM, et al
    Association of Lower Rostral Anterior Cingulate GABA+ and Dysregulated Cortisol Stress Response With Altered Functional Connectivity in Young Adults With Lifetime Depression: A Multimodal Imaging Investigation of Trait and State Effects.
    Am J Psychiatry. 2024 Apr 30:appiajp20230382. doi: 10.1176/appi.ajp.20230382.
    

    >> Share

    
    
64. KAVIRAJAN H
    Neglect of Adverse Effects in Treatment Guidelines for Depression.
    Am J Psychiatry. 2024;181:342-345.
    

    >> Share

    
    March 2024
65. STEFFENS DC
    Late-Life Depression, Antidepressant Treatment, and Cognition: The Short Haul and the Long Haul.
    Am J Psychiatry. 2024;181:183-185.
    

    >> Share

    
    
66. PHILLIPS ML
    Multimodal Predictors of Treatment Response in Major Depressive Disorder: Advancing Personalized Medicine in Psychiatry.
    Am J Psychiatry. 2024;181:180-182.
    

    >> Share

    
    
67. POIROT MG, Ruhe HG, Mutsaerts HMM, Maximov II, et al
    Treatment Response Prediction in Major Depressive Disorder Using Multimodal MRI and Clinical Data: Secondary Analysis of a Randomized Clinical Trial.
    Am J Psychiatry. 2024;181:223-233.
    

    >> Share

    
    February 2024
68. AINSWORTH NJ, Marawi T, Maslej MM, Blumberger DM, et al
    Cognitive Outcomes After Antidepressant Pharmacotherapy for Late-Life Depression: A Systematic Review and Meta-Analysis.
    Am J Psychiatry. 2024 Feb 7:appiajp20230392. doi: 10.1176/appi.ajp.20230392.
    

    >> Share

    
    January 2024
69. KALIN NH
    Improving Clinical Outcomes and Informing New Interventions.
    Am J Psychiatry. 2024;181:1-3.
    

    >> Share

    
    
70. WALASZEK A
    Optimizing the Treatment of Late-Life Depression.
    Am J Psychiatry. 2024;181:7-10.
    

    >> Share

    
    
71. RUBINOW DR
    Suicide and the Menstrual Cycle.
    Am J Psychiatry. 2024;181:11-13.
    

    >> Share

    
    
72. BATAIL JV, Feyder MT, Bentzley BS, Williams NR, et al
    An Avenue for Optimization of Theta Burst Stimulation Protocols? Comments on the FOUR-D Randomized Noninferiority Clinical Trial.
    Am J Psychiatry. 2024;181:68-70.
    

    >> Share

    
    December 2023
73. KALIN NH
    Adversity and Resilience, Postpartum Depression, Suicide, and Racial/Ethnic Disparities.
    Am J Psychiatry. 2023;180:859-861.
    

    >> Share

    
    
74. ADAMS JAM, Chandra P, Mehta D
    The First Large GWAS Meta-Analysis for Postpartum Depression.
    Am J Psychiatry. 2023;180:862-864.
    

    >> Share

    
    
75. STOWE ZN
    Perinatal Mental Health: Advances and Opportunities.
    Am J Psychiatry. 2023;180:874-877.
    

    >> Share

    
    October 2023
76. GUINTIVANO J, Byrne EM, Kiewa J, Yao S, et al
    Meta-Analyses of Genome-Wide Association Studies for Postpartum Depression.
    Am J Psychiatry. 2023 Oct 18:appiajp20230053. doi: 10.1176/appi.ajp.20230053.
    

    >> Share

    
    
77. ISHTIAK-AHMED K, Musliner KL, Christensen KS, Mortensen EL, et al
    Real-World Evidence on Clinical Outcomes of Commonly Used Antidepressants in Older Adults Initiating Antidepressants for Depression: A Nationwide Cohort Study in Denmark.
    Am J Psychiatry. 2023 Oct 18:appiajp20230356. doi: 10.1176/appi.ajp.20230356.
    

    >> Share

    
    
78. SHACKMAN AJ, Gee DG
    Maternal Perinatal Stress Associated With Offspring Negative Emotionality, But the Underlying Mechanisms Remain Elusive.
    Am J Psychiatry. 2023;180:708-711.
    

    >> Share

    
    
79. KALIN NH
    Stress, Heritability, and Genetic Factors Influencing Depression, PTSD, and Suicidal Behavior.
    Am J Psychiatry. 2023;180:699-702.
    

    >> Share

    
    
80. LYNALL ME, McIntosh AM
    The Heterogeneity of Depression.
    Am J Psychiatry. 2023;180:703-704.
    

    >> Share

    
    
81. NGUYEN TD, Kowalec K, Pasman J, Larsson H, et al
    Genetic Contribution to the Heterogeneity of Major Depressive Disorder: Evidence From a Sibling-Based Design Using Swedish National Registers.
    Am J Psychiatry. 2023;180:714-722.
    

    >> Share

    
    
82. FARHAT LC, Blakey R, Davey Smith G, Fujita A, et al
    Networks of Neurodevelopmental Traits, Socioenvironmental Factors, Emotional Dysregulation in Childhood, and Depressive Symptoms Across Development in Two U.K. Cohorts.
    Am J Psychiatry. 2023;180:755-765.
    

    >> Share

    
    
83. CHATZINAKOS C, Pernia CD, Morrison FG, Iatrou A, et al
    Single-Nucleus Transcriptome Profiling of Dorsolateral Prefrontal Cortex: Mechanistic Roles for Neuronal Gene Expression, Including the 17q21.31 Locus, in PTSD Stress Response.
    Am J Psychiatry. 2023;180:739-754.
    

    >> Share

    
    
84. DOCHERTY AR, Mullins N, Ashley-Koch AE, Qin X, et al
    GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors.
    Am J Psychiatry. 2023;180:723-738.
    

    >> Share

    
    September 2023
85. PINE DS
    Zuranolone Treatment for Depression: Steady Progress in Mechanism-Focused Therapeutics?
    Am J Psychiatry. 2023;180:631-633.
    

    >> Share

    
    
86. KALIN NH
    Seeking New Solutions Addressing Structural Racism, Childhood Trauma, Suicidal Behaviors Across Sexual Orientations, and Postpartum Depression.
    Am J Psychiatry. 2023;180:625-628.
    

    >> Share

    
    
87. CLAYTON AH, Lasser R, Parikh SV, Iosifescu DV, et al
    Zuranolone for the Treatment of Adults With Major Depressive Disorder: A Randomized, Placebo-Controlled Phase 3 Trial.
    Am J Psychiatry. 2023;180:676-684.
    

    >> Share

    
    July 2023
88. DELIGIANNIDIS KM, Meltzer-Brody S, Maximos B, Peeper EQ, et al
    Zuranolone for the Treatment of Postpartum Depression.
    Am J Psychiatry. 2023 Jul 26:appiajp20220785. doi: 10.1176/appi.ajp.20220785.
    

    >> Share

    
    
89. JESTER DJ, Kohn JN, Tibirica L, Thomas ML, et al
    Differences in Social Determinants of Health Underlie Racial/Ethnic Disparities in Psychological Health and Well-Being: Study of 11,143 Older Adults.
    Am J Psychiatry. 2023;180:483-494.
    

    >> Share

    
    April 2023
90. BIERNACKA JM
    Do Polygenic Scores Inform Psychiatric Disease Risk After Considering Family History?
    Am J Psychiatry. 2023;180:256-258.
    

    >> Share

    
    March 2023
91. ELBAU IG, Lynch CJ, Downar J, Vila-Rodriguez F, et al
    Functional Connectivity Mapping for rTMS Target Selection in Depression.
    Am J Psychiatry. 2023;180:230-240.
    

    >> Share

    
    
92. THASE ME
    A New Option for Depressed Patients Who Do Not Respond to Antidepressant Medications.
    Am J Psychiatry. 2023;180:188-189.
    

    >> Share

    
    
93. KALIN NH
    Insights and Advances Into Treatments for Major Depression.
    Am J Psychiatry. 2023;180:173-176.
    

    >> Share

    
    
94. JHA MK, Mathew SJ
    Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.
    Am J Psychiatry. 2023;180:190-199.
    

    >> Share

    
    
95. NUNES EV
    Alcohol and the Etiology of Depression.
    Am J Psychiatry. 2023;180:179-181.
    

    >> Share

    
    
96. SACHS GS, Yeung PP, Rekeda L, Khan A, et al
    Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.
    Am J Psychiatry. 2023;180:241-251.
    

    >> Share

    
    
97. DUNLOP BW, Cha J, Choi KS, Rajendra JK, et al
    Shared and Unique Changes in Brain Connectivity Among Depressed Patients After Remission With Pharmacotherapy Versus Psychotherapy.
    Am J Psychiatry. 2023;180:218-229.
    

    >> Share

    
    
98. HASSERIS S, Albinana C, Vilhjalmsson BJ, Mortensen PB, et al
    Polygenic Risk and Episode Polarity Among Individuals With Bipolar Disorder.
    Am J Psychiatry. 2023;180:200-208.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share